This is an exciting alternative in the treatment of vaircose veins

Founded in 1995 by Michael Laufer, M.D, VNUS used its medical and engineering expertise in developing a minimally invasive alternative to vein stripping. The Closure procedure was first used in Europe beginning in 1998. As of March 2003, more than 20,000 procedures have been performed worldwide. The Closure procedure became available in the United States in March 1999. The mission of VNUS is to help patients look and feel better with safe, fast and more effective treatments. Collectively, top management has more than 75 years of experience in the industry, and collaborates with a widely respected group of physician advisors and clinical investigators throughout the world. Safety Summary As with any medical intervention, potential risks and complications exist with the Closure procedure. You should consult your physician to determine if your individual condition presents any special risks. Although a summary of potential complications of the Closure procedure is provided, you are encouraged to review these with your doctor at the time of consultation. Indication: The Closure System is intended for endovascular coagulation of blood vessels in patients with superficial venous reflux. Contraindication: Patients with thrombus in the vein segment to be treated. Potential Risks & Complications: * Potential complications include, but are not limited to the following: vessel perforation, thrombosis, pulmonary embolism, phlebitis, hematoma, infection, paresthesia, skin burn. * Treatment of veins located very close to the skin surface may result in a skin burn. * Paresthesia may occur from thermal damage to adjacent sensory nerves. The risk of paresthesia is higher with treatment at or below the calf.
Other great cosmetic and hair resoration sites